Data / Form D filings / GRI BIO OPERATIONS, INC.
GRI BIO OPERATIONS, INC.: Form D filings
GRI BIO OPERATIONS, INC., a biotechnology company in La Jolla, CA, filed 4 Form D notices with the SEC between 2015 and 2023. The latest, on April 28, 2023, reports $15.6 million sold of a $15.6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, La Jolla, CA, 92037
- Phone
- (619) 400-1171
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1639824
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | New notice | $15,583,333 | $15,583,333 | 1 | Apr 21, 2023 | sec.gov | |
| Dec 22, 2022 | New notice | $2,500,100 | $1,250,050 | $1,250,050 | 1 | Dec 13, 2022 | sec.gov |
| Nov 8, 2018 | New notice | $5,710,792 | $5,710,792 | 4 | Nov 2, 2018 | sec.gov | |
| Apr 17, 2015 | New notice | $6,378,000 | $4,378,000 | $2,000,000 | 2 | Apr 2, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Walter Marc Hertz | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 24, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GRI BIO OPERATIONS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.